Suppression of MAPK7 has been shown to increase E-cadherin expression, thereby reducing migration and metastasis in breast cancer cells; in animal models, it regulates tumor growth and has been linked to metastatic risk in clinical studies of breast cancer [84,85,86,87]. This evidence concerns the gene MAPK7 and breast carcinoma.